| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/25/1992 | WO1992010287A1 Method of producing collagen particles, and the use of such particles as substrates for active substances |
| 06/25/1992 | WO1992010212A1 Anthracycline-conjugates |
| 06/25/1992 | WO1992010200A1 Functional interactions between glial s-100b and central nervous system serotonergic neurons |
| 06/25/1992 | WO1992010197A1 Substances of polypeptide nature useful in human therapy |
| 06/25/1992 | WO1992008731A3 T-cadherin adhesion molecule |
| 06/25/1992 | DE4042008A1 Vasopressin-derivate Vasopressin derivatives |
| 06/25/1992 | DE4041464A1 5-ht(pfeil abwaerts)1(pfeil abwaerts)-rezeptor 5-ht (Down Arrow) 1 (down arrow) receptor |
| 06/25/1992 | DE4041304A1 Von strukturproteinen des hepatitis c-virus abgeleitete polypeptide, testkits, die diese polypeptide enthalten und impfstoffe gegen infektionen von hepatitis c-viren Of structural proteins of the hepatitis C virus-derived polypeptides, test kits containing such polypeptides, and vaccines against infection by hepatitis C virus |
| 06/25/1992 | DE4041189A1 New peptides as TNF agonists and antagonists - for treatment of neoplastic and auto:immune disease, infection, inflammation and transplant rejection |
| 06/25/1992 | DE4041188A1 New peptide(s) of TNF agonists and antagonists - used for treating neoplastic and autoimmune disease, infection, inflammation and transplant rejection |
| 06/25/1992 | DE4041187A1 Neue tnf-peptide New tnf-peptide |
| 06/25/1992 | DE4041059A1 New peptide for treating arthritis - contg. aminoacid sequence comprising epitope of fragment from human collagen |
| 06/25/1992 | CA2614365A1 Dna expression systems based on alphaviruses |
| 06/25/1992 | CA2098292A1 Dna expression systems based on alphaviruses |
| 06/25/1992 | CA2098188A1 Sperm cell surface protein ph-20 use in a contraceptive vaccine |
| 06/25/1992 | CA2097935A1 Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis |
| 06/25/1992 | CA2077350A1 Dna coding for growth-inhibitory factor and use thereof |
| 06/25/1992 | CA2057963A1 Chimaeric influenza-hiv vaccine |
| 06/25/1992 | CA2057761A1 Protective plasmodium falciparum hybrid proteins which contain part-sequences of the malaria antigens hrpii and serp, the preparation and use thereof |
| 06/25/1992 | CA2057675A1 Peptide inhibitors of ras-gap interaction |
| 06/24/1992 | EP0491675A1 Improvements relating to growth factors |
| 06/24/1992 | EP0491628A2 Lipopeptide inducing T-cytotoxic lymphocytes and their use as vaccines |
| 06/24/1992 | EP0491361A2 Short peptides having the effect of insulin |
| 06/24/1992 | EP0491125A1 Vaccines against equine herpes viruses and their preparation |
| 06/24/1992 | EP0491077A1 A composition used as a therapeutic agent against chronic viral hepatic diseases |
| 06/24/1992 | EP0491032A1 Substance with interleukin-8 inhibiting activity and process for its preparation |
| 06/24/1992 | EP0490975A1 Interleukin-4 receptors |
| 06/24/1992 | EP0490951A1 Fragments of nucleic acids derived from an appropriate mycobacteria genome, their applications in the diagnosis of mycobateria infections and plasmides containing said fragments. |
| 06/24/1992 | EP0484325A4 Azido-substituted octopamine agonists and the use thereof to control invertebrate pests |
| 06/24/1992 | EP0462207A4 Serpin resistant chymotrypsin superfamily proteases, particularly pai-1 resistant +-pa, complementary inhibitor mutants; compositions; genes; expression |
| 06/24/1992 | EP0444158A4 Conjugated polypeptides and methods for their preparation and use |
| 06/24/1992 | CN1062172A Ribosome-inactivating proteins, inactive precursor forms thereof, process for making and method of using |
| 06/24/1992 | CN1062168A Chicken anemia virus vaccine and diagnostic |
| 06/24/1992 | CN1062081A Hair growth regulating composition comprising epithelium cell supernatant-derived growth factor |
| 06/23/1992 | WO1992011362A1 Serotonine receptor of class 1: the 5-ht1x receptors |
| 06/23/1992 | US5124443 cDNA clones encoding chicken egg white cystatin |
| 06/23/1992 | US5124440 Antibody and T cell recognition sites on glycoproteins comprising the GCI complex of human cytomegalovirus |
| 06/23/1992 | US5124438 Chemically modified proteins and colorant formulations containing the same |
| 06/23/1992 | US5124437 High-molecular-weight missile drug carriers |
| 06/23/1992 | US5124316 Applying growth promoting amount of polypeptide growth factor |
| 06/23/1992 | US5124314 Treatment of diabetes or hypoglycemia |
| 06/23/1992 | US5124263 Recombination resistant retroviral helper cell and products produced thereby |
| 06/23/1992 | US5124255 CKS method of protein synthesis |
| 06/23/1992 | US5124251 CD3 ζ co-associated complex on CD16- NK cells |
| 06/23/1992 | US5124153 Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products |
| 06/23/1992 | CA2098706A1 5-ht1x receptor |
| 06/23/1992 | CA1304193C Grf analogs v |
| 06/23/1992 | CA1304192C Grf analogs vi |
| 06/23/1992 | CA1304025C Modified zein |
| 06/23/1992 | CA1304024C Covalently linked polypeptide cell modulators |
| 06/23/1992 | CA1304023C .beta.-UROGASTRONE GENE, CORRESPONDING RECOMBINANT PLASMIDS, CORRESPONDING TRANSFORMANTS AND PREPARATION THEREOF AND OF .beta.-UROGASTRONE |
| 06/23/1992 | CA1304022C Insulin precursors, process for their preparation and process for preparing human insulin from such insulin precursors |
| 06/23/1992 | CA1304021C Microbiological process for the preparation of a protein by culturing a mutant bacterial strain |
| 06/23/1992 | CA1304020C High level expression in yeast |
| 06/23/1992 | CA1303988C Eimeria acervulina immunogens |
| 06/23/1992 | CA1303980C Monoclonal antibodies against glycolipid antigens, methods of producing these antibodies and use therefor |
| 06/22/1992 | WO1992011387A1 Diagnosis for porcine malignant hyperthermia |
| 06/22/1992 | WO1992011364A1 Biosynthetic pdgf antagonists |
| 06/22/1992 | WO1992011290A1 Medicaments for the treatment of papillomavirus diseases |
| 06/22/1992 | WO1992011286A1 Oxidation resistant variants of parathyroid hormone |
| 06/22/1992 | WO1992011021A1 Angiogenic peptides |
| 06/22/1992 | CA2098926A1 Medicaments for the treatment of papillomavirus diseases |
| 06/22/1992 | CA2098922A1 Neuronal cholinergic differentiation factor |
| 06/22/1992 | CA2098283A1 Oxidation resistant variants of parathyroid hormone |
| 06/22/1992 | CA2097603A1 Biosynthetic pdgf antagonists |
| 06/22/1992 | CA2079702A1 Diagnosis for porcine malignant hyperthermia |
| 06/22/1992 | CA2058379A1 Babesial protease antigen |
| 06/22/1992 | CA2058280A1 Expression systems |
| 06/22/1992 | CA2035810A1 Enrichment of delta-bilipeptides solutions |
| 06/21/1992 | WO1992011273A1 Pcr primers for detection of legionella species and methods for controlling visual intensity in hybridization assays |
| 06/21/1992 | WO1992011272A1 Optimization of binding proteins |
| 06/21/1992 | WO1992011120A1 Method and apparatus for granulation |
| 06/21/1992 | CA2098824A1 Optimization of binding proteins |
| 06/21/1992 | CA2098600A1 Method and apparatus for granulation |
| 06/21/1992 | CA2075493A1 Pcr primers for detection of legionella species and methods for controlling visual intensity in hybridization assays |
| 06/20/1992 | WO1992011378A1 A method of constructing synthetic leader sequences |
| 06/20/1992 | WO1992011018A1 Improved humanized immunoglobulins |
| 06/20/1992 | CA2098731A1 Method of constructing synthetic leader sequences |
| 06/20/1992 | CA2057715A1 Method for enhancing the structural stability of recombinant dna expression vectors |
| 06/19/1992 | WO1992011377A1 Tissue plasminogen activator substitution variant |
| 06/19/1992 | WO1992011360A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 06/19/1992 | CA2098484A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 06/18/1992 | WO1992011356A1 Thrombolytic peptide, production thereof and thrombolytic agent |
| 06/18/1992 | WO1992011282A1 Polypeptide fraction affording protection to cells against mechanical damage and assay |
| 06/18/1992 | CA2076001A1 Polypeptide fraction affording protection to cells against mechanical damage and assay |
| 06/17/1992 | EP0490806A2 Nasal pharmaceutical compositions |
| 06/17/1992 | EP0490667A2 HIV protease inhibitors |
| 06/17/1992 | EP0490410A1 TXA2 Receptor and gene encoding the same |
| 06/17/1992 | EP0490384A1 Process for the production of pasteurized and iron-free human transferrin |
| 06/17/1992 | EP0490383A2 Peptides of the HIV-gag protein, their preparation and use |
| 06/17/1992 | EP0490259A2 Aminoacid and peptid derivatives with renin inhibiting properties |
| 06/17/1992 | EP0490249A1 Process for the enzymatic preparation of GRF(1-44)NH2 |
| 06/17/1992 | EP0490233A1 Monoclonal antibodies against Bgl III-hybrid interferons, their use and process for preparing them |
| 06/17/1992 | EP0490077A1 Antisense oligonucleotides for treatment of cancer |
| 06/17/1992 | EP0489968A1 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 06/17/1992 | EP0489868A1 Transgenic animal model for viral infections |
| 06/17/1992 | EP0489846A1 Antisense oligonucleotides to c-abl proto-oncogene |
| 06/17/1992 | EP0489837A1 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction |
| 06/17/1992 | EP0489830A1 Expression of alpha-macroglobulins |
| 06/17/1992 | EP0489780A1 Fusion proteins, their preparation and use |